Alembic Pharmaceuticals has appointed Rajkumar Baheti as a Non-Executive Non-Independent Director, effective April 1, 2026. The appointment, based on the Nomination and Remuneration Committee’s recommendation, is subject to member approval via postal ballot. Baheti, liable to retire by rotation, brings 44 years of experience in corporate finance, governance, and regulatory compliance.
Board Strengthens Leadership
Alembic Pharmaceuticals announced the appointment of Rajkumar Baheti as a Non-Executive Non-Independent Director. This decision was made based on the recommendation of the Nomination and Remuneration Committee during a recent board meeting.
Appointment Details
Rajkumar Baheti’s appointment is effective from April 1, 2026, following his tenure as an Executive Director, which ends on March 31, 2026. He will be liable to retire by rotation, and his position is subject to the approval of the members via a postal ballot.
Rajkumar Baheti’s Background
Mr. Baheti is a Commerce graduate and a fellow member of both the Institute of Chartered Accountants of India and the Institute of Company Secretaries of India. He brings substantial expertise with 44 years of extensive professional experience in areas, such as corporate finance, financial governance, regulatory compliance and complex financial matters.
Source: BSE